Clinical Trial Update: Carbidopa for the Treatment of Excessive Blood Pressure Variability [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating carbidopa for treatment of excessive blood pressure variability in familial dysautonomia and baroreflex failure syndrome; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Baroreflex Failure Syndrome
• Dysautonomia Familial

Drugs mentioned

• Carbidopa (Carbidopa)

Snippet

Sponsor: NYU Langone Health | Conditions: Dysautonomia, Familial, Baroreflex Failure Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2022-02-09